Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment
Autoři | |
---|---|
Rok publikování | 2013 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | LEUKEMIA & LYMPHOMA |
Fakulta / Pracoviště MU | |
Citace | |
Doi | http://dx.doi.org/10.3109/10428194.2012.738816 |
Obor | Onkologie a hematologie |
Klíčová slova | SCLEROMYXEDEMA; DEXAMETHASONE; ADULTORUM; BUSCHKE; THALIDOMIDE; DISORDERS; PATIENT; DISEASE |
Popis | Scleredema is a rare scleroderma-like fi bromucinosis characterized by progressive thickening of the skin caused by excessive collagen and mucin depositions in the dermis. Various treatment regimens have been proposed, however with inconsistent outcomes. Herein we are the fi rst to report a complete dermatological and hematological remission in a patient with multiple myeloma associated scleredema after bortezomib-based chemotherapy. |
Související projekty: |
|